Investment and restructuring create new opportunities for STERIS
STERIS Corporation has recently announced a restructuring of its European operations to ensure the Company remains at the forefront of infection prevention and surgical products and services around the globe.
- (1888PressRelease) July 27, 2011 - STERIS Corporation has recently announced a restructuring of its European operations to ensure the Company remains at the forefront of infection prevention and surgical products and services around the globe. Transfer of STERIS's EMEA Healthcare Headquarters from Basingstoke to the Company's new Headquarters in Bordeaux, France, will ensure closer ties between the technical and application specialists and R&D teams, allowing more rapid development of new products to meet the changing needs of the market.
This centralisation of services has created an exciting opportunity for the Company to establish a new Centre of Excellence for Sterility Assurance in Leicester. Based at the UK manufacturing site of Albert Browne Limited - STERIS's sterility assurance business - this purpose-built facility will provide technical training and educational support for all cleaning chemistries, sterility assurance systems and applied infection control products. The Centre of Excellence will also feature a research centre to optimise instrument processing and customer workflows for improved patient outcomes, and incorporate the UK headquarters for STERIS's Healthcare Sales, Customer Operations and Services divisions.
Alan Charlton, General Manager of Albert Browne Ltd, commented: "This new venture will provide our customers around the world with exceptional services to help them establish, implement and optimise their infection prevention and sterile services. By working closely with our application specialists and technical teams, customers can be certain that they have access to the appropriate expertise at the right time, reinforcing our 'world class and globally trusted' ethos and providing cost and efficiency savings which will ultimately lead to better care for patients."
About STERIS
STERIS Corporation is a leading provider of infection prevention and surgical products and services, focused primarily on critical healthcare, pharmaceutical and research markets. The Company's more than 5,000 dedicated employees around the world work together to supply a broad array of solutions by offering a combination of equipment, consumables and services that enhance Customer productivity and quality, and help make the world a safer place. The Company is listed on the New York Stock Exchange under the symbol STE. For more information, please visit www.steris.com.
For further information, contact:
Sarah Pilbrow
STERIS
STERIS House
Jays Close
Viables
Basingstoke
Hampshire
RG22 4AX
Tel: +44 (0)1256 840 400
Fax: +44 (0)1256 866 503
Website: www.STERIS.com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam